COO, CFO AND SECRETARY
Fri, May 3, 2024
May 3
8,078 shares @ $17.85
Decreased holdings by -3.60%
10th largest trade (out of 143)
Planned (10b5-1)Positive 90D History
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
69% win rate · +5.4% median edge vs SPY (13 trades, 90-day · small sample)
Price 25% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology